Ellen Heitzer Selected Research

N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)

1/2022	The clinical features of polymerase proof-reading associated polyposis (PPAP) and recommendations for patient management.
2/2014	Replicative DNA polymerase mutations in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ellen Heitzer Research Topics

Disease

49	Neoplasms (Cancer) 01/2022 - 07/2008
14	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 03/2009
11	Circulating Neoplastic Cells 08/2020 - 01/2013
8	Breast Neoplasms (Breast Cancer) 07/2022 - 07/2013
8	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2013
4	Carcinogenesis 07/2022 - 07/2008
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
4	Prostatic Neoplasms (Prostate Cancer) 08/2020 - 01/2013
4	Disease Progression 01/2020 - 01/2013
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
3	Chordoma 01/2021 - 04/2016
3	Melanoma (Melanoma, Malignant) 11/2019 - 12/2015
2	Adenocarcinoma of Lung 01/2021 - 01/2017
2	Aneuploidy (Aneuploid) 01/2021 - 01/2016
2	Carcinoma (Carcinomatosis) 01/2021 - 02/2014
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2019
2	Residual Neoplasm 01/2020 - 01/2017
2	Adenoma (Adenomas) 12/2015 - 02/2014
2	Cancer Pain 09/2013 - 10/2012
2	Pain (Aches) 09/2013 - 11/2012
1	Starvation 05/2022
1	Edema (Dropsy) 06/2021
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Brain Neoplasms (Brain Tumor) 11/2019
1	Coffin-Siris syndrome 01/2019
1	Pathologic Processes 01/2018
1	Pleural Effusion (Pleural Effusions) 01/2017
1	Leiomyosarcoma 10/2016
1	Smooth Muscle Tumor 10/2016
1	Leiomyoma (Uterine Fibroids) 10/2016

Drug/Important Bio-Agent (IBA)

24	Circulating Tumor DNAIBA 01/2022 - 01/2013
23	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 07/2008
12	Cell-Free Nucleic AcidsIBA 01/2021 - 06/2015
10	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2012
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2012
3	Messenger RNA (mRNA)IBA 07/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2016
3	Exonucleases (3' 5' Exonuclease)IBA 01/2021 - 02/2014
3	Androgen Receptors (Androgen Receptor)IBA 08/2020 - 01/2018
3	Biological ProductsIBA 09/2017 - 11/2012
2	Protein Isoforms (Isoforms)IBA 07/2022 - 10/2016
2	GlycogenIBA 05/2022 - 07/2018
2	N- (3- phenyl- n- propyl)- 1- phenyl- 2- aminopropane (PPAP)IBA 01/2022 - 02/2014
2	CytokinesIBA 06/2021 - 11/2012
2	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2021 - 02/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2014
2	LigandsIBA 01/2021 - 01/2019
2	Monoclonal AntibodiesIBA 01/2020 - 03/2014
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 10/2019
2	Tumor Biomarkers (Tumor Markers)IBA 08/2019 - 01/2019
2	abirateroneIBA 01/2018 - 01/2018
2	Formaldehyde (Formol)FDA Link 06/2014 - 03/2009
2	ParaffinIBA 06/2014 - 03/2009
2	Opioid Analgesics (Opioids)IBA 09/2013 - 10/2012
1	Long Noncoding RNAIBA 07/2022
1	A-factor (Streptomyces)IBA 07/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 07/2022
1	Insulin ReceptorIBA 05/2022
1	Phosphotransferases (Kinase)IBA 05/2022
1	EnzymesIBA 05/2022
1	Hormones (Hormone)IBA 01/2022
1	AlpelisibIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 11/2021
1	Peptides (Polypeptides)IBA 10/2021
1	osimertinibIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	regorafenibIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Heme (Haem)IBA 01/2021
1	N 30IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 06/2020
1	Angiogenesis InhibitorsIBA 01/2020
1	Edetic Acid (EDTA)FDA Link 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	MicroRNAs (MicroRNA)IBA 10/2019
1	Complement System Proteins (Complement)IBA 10/2019
1	Circulating MicroRNAIBA 10/2019
1	AntigensIBA 08/2019
1	Carcinoembryonic AntigenIBA 08/2019
1	Nucleosomes (Nucleosome)IBA 01/2019
1	Chloroquine (Aralen)FDA LinkGeneric 07/2018
1	enzalutamideIBA 01/2018
1	Dextran SulfateIBA 01/2018
1	AzoxymethaneIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2018
1	LuciferasesIBA 09/2017

Therapy/Procedure

17	Therapeutics 12/2021 - 03/2014
4	Palliative Care (Palliative Therapy) 12/2013 - 10/2012
2	Drug Therapy (Chemotherapy) 11/2020 - 04/2016
2	Castration 08/2020 - 01/2013
1	Immunotherapy 01/2022
1	Neoadjuvant Therapy 01/2022
1	Investigational Therapies (Experimental Therapy) 11/2019